Belarus

Belarus

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.94 (0.28 - 11.95) 2015 Modelled WHO
4.3 (3.90 - 4.80) 2016 Modelled Razavi-Shearer et al, 2018
4.6 (4.21 - 5.02) 2013 Modelled Schweitzer et al, 2015
0.55 (0.47 - 0.63) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.61 (0.52 - 0.69) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.52 - 0.70) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.54 - 0.72) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.54 - 0.75) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.56 - 0.76) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.58 - 0.78) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.60 - 0.80) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.62 - 0.82) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.63 - 0.84) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.65 - 0.85) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.87) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.68 - 0.90) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.70 - 0.93) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.70 - 0.94) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.71 - 0.95) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.71 - 0.95) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.73 - 0.97) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.73 - 0.99) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.74 - 1.01) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.75 - 1.02) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.78 - 1.03) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.80 - 1.05) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.82 - 1.08) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.82 - 1.09) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.82 - 1.08) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.82 - 1.07) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.81 - 1.06) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.80 - 1.06) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.79 - 1.06) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.51 - 0.67) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.2 (0.03 - 1.53) 2015 Modelled WHO
0.04 (0.03 - 0.05) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.06 (0.04 - 0.07) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.07) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.07) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.08) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.09) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.10) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.10) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.16 (0.12 - 0.19) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.21 (0.16 - 0.25) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.26 (0.20 - 0.33) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.39 (0.30 - 0.48) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.47 - 0.75) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.66 - 1.03) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.80 - 1.27) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.86 - 1.38) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.86 - 1.38) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.86 - 1.36) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.09 (0.85 - 1.35) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.83 - 1.33) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.80 - 1.31) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.20 - 0.42) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
404,000 (374,000 - 458,000) 2016 Modelled Razavi-Shearer et al, 2018
52,625 (44,889 - 59,736) 2019 Modelled IHME, GBD 2019 (accessed 2020)
53,879 (45,888 - 61,128) 2019 Modelled IHME, GBD 2019 (accessed 2022)
55,103 (47,432 - 62,275) 2018 Modelled IHME, GBD 2019 (accessed 2022)
55,751 (47,551 - 63,538) 2017 Modelled IHME, GBD 2019 (accessed 2022)
57,569 (48,902 - 65,207) 2016 Modelled IHME, GBD 2019 (accessed 2022)
59,817 (49,627 - 68,441) 2015 Modelled IHME, GBD 2019 (accessed 2022)
61,097 (51,191 - 69,816) 2014 Modelled IHME, GBD 2019 (accessed 2022)
62,735 (53,243 - 71,359) 2013 Modelled IHME, GBD 2019 (accessed 2022)
64,558 (55,437 - 73,344) 2012 Modelled IHME, GBD 2019 (accessed 2022)
66,406 (57,255 - 75,778) 2011 Modelled IHME, GBD 2019 (accessed 2022)
67,933 (58,254 - 78,123) 2010 Modelled IHME, GBD 2019 (accessed 2022)
69,523 (60,279 - 79,230) 2009 Modelled IHME, GBD 2019 (accessed 2022)
71,664 (61,905 - 81,206) 2008 Modelled IHME, GBD 2019 (accessed 2022)
74,022 (63,584 - 84,340) 2007 Modelled IHME, GBD 2019 (accessed 2022)
76,235 (65,339 - 87,337) 2006 Modelled IHME, GBD 2019 (accessed 2022)
77,780 (66,677 - 89,774) 2005 Modelled IHME, GBD 2019 (accessed 2022)
79,145 (67,290 - 90,471) 2004 Modelled IHME, GBD 2019 (accessed 2022)
81,073 (68,633 - 91,500) 2003 Modelled IHME, GBD 2019 (accessed 2022)
83,314 (70,248 - 94,024) 2002 Modelled IHME, GBD 2019 (accessed 2022)
85,506 (71,625 - 96,862) 2001 Modelled IHME, GBD 2019 (accessed 2022)
87,138 (72,331 - 98,788) 2000 Modelled IHME, GBD 2019 (accessed 2022)
88,787 (74,141 - 99,960) 1999 Modelled IHME, GBD 2019 (accessed 2022)
91,008 (77,103 - 101,929) 1998 Modelled IHME, GBD 2019 (accessed 2022)
93,302 (79,689 - 104,391) 1997 Modelled IHME, GBD 2019 (accessed 2022)
95,167 (81,350 - 107,005) 1996 Modelled IHME, GBD 2019 (accessed 2022)
95,987 (82,175 - 109,029) 1995 Modelled IHME, GBD 2019 (accessed 2022)
95,953 (82,102 - 108,160) 1994 Modelled IHME, GBD 2019 (accessed 2022)
95,684 (82,080 - 107,327) 1993 Modelled IHME, GBD 2019 (accessed 2022)
95,144 (80,971 - 106,165) 1992 Modelled IHME, GBD 2019 (accessed 2022)
94,316 (79,868 - 105,874) 1991 Modelled IHME, GBD 2019 (accessed 2022)
93,194 (78,987 - 105,260) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.72 (2.50 - 5.32) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.21 (1.72 - 2.80) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.78 - 2.94) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.87 - 3.05) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.78 (2.13 - 3.49) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.68 (2.06 - 3.39) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.05 (2.35 - 3.82) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.28 (2.53 - 4.11) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.42 - 3.92) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.52 (2.71 - 4.45) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.88 (2.99 - 4.92) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.05 (3.12 - 5.14) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.66 (3.57 - 5.94) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5.64 (4.32 - 7.22) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.95 (4.56 - 7.66) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.27 (4.78 - 8.11) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.99 (5.33 - 9.01) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7.04 (5.39 - 9.05) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.25 (4.72 - 8.16) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6.68 (5.10 - 8.70) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.83 (4.38 - 7.59) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.67 (4.23 - 7.45) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.7 (4.27 - 7.48) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.67 (3.55 - 6.10) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.91 (2.95 - 5.14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
4.41 (3.37 - 5.74) 2013 Modelled IHME, GBD 2019 (accessed 2022)
4.19 (3.16 - 5.48) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (2.82 - 5) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.8 (2.73 - 5.17) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.75 (2.53 - 5.30) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (2.50 - 5.32) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
678 2016 Modelled WHO
231 (180 - 293) 1990 Modelled IHME, GBD 2019 (accessed 2022)
242 (187 - 308) 1991 Modelled IHME, GBD 2019 (accessed 2022)
254 (197 - 321) 1992 Modelled IHME, GBD 2019 (accessed 2022)
292 (224 - 366) 1994 Modelled IHME, GBD 2019 (accessed 2022)
282 (217 - 356) 1993 Modelled IHME, GBD 2019 (accessed 2022)
319 (246 - 400) 1995 Modelled IHME, GBD 2019 (accessed 2022)
328 (253 - 409) 1996 Modelled IHME, GBD 2019 (accessed 2022)
341 (263 - 427) 1997 Modelled IHME, GBD 2019 (accessed 2022)
364 (280 - 461) 1998 Modelled IHME, GBD 2019 (accessed 2022)
399 (308 - 507) 1999 Modelled IHME, GBD 2019 (accessed 2022)
415 (320 - 526) 2000 Modelled IHME, GBD 2019 (accessed 2022)
474 (363 - 605) 2001 Modelled IHME, GBD 2019 (accessed 2022)
570 (436 - 730) 2002 Modelled IHME, GBD 2019 (accessed 2022)
597 (457 - 769) 2003 Modelled IHME, GBD 2019 (accessed 2022)
625 (476 - 808) 2004 Modelled IHME, GBD 2019 (accessed 2022)
692 (528 - 892) 2005 Modelled IHME, GBD 2019 (accessed 2022)
693 (530 - 891) 2006 Modelled IHME, GBD 2019 (accessed 2022)
654 (499 - 852) 2007 Modelled IHME, GBD 2019 (accessed 2022)
609 (461 - 796) 2008 Modelled IHME, GBD 2019 (accessed 2022)
566 (425 - 738) 2009 Modelled IHME, GBD 2019 (accessed 2022)
549 (409 - 721) 2010 Modelled IHME, GBD 2019 (accessed 2022)
550 (412 - 721) 2011 Modelled IHME, GBD 2019 (accessed 2022)
449 (341 - 587) 2012 Modelled IHME, GBD 2019 (accessed 2022)
424 (323 - 551) 2013 Modelled IHME, GBD 2019 (accessed 2022)
374 (282 - 492) 2015 Modelled IHME, GBD 2019 (accessed 2022)
365 (270 - 478) 2016 Modelled IHME, GBD 2019 (accessed 2022)
402 (303 - 525) 2014 Modelled IHME, GBD 2019 (accessed 2022)
362 (261 - 494) 2017 Modelled IHME, GBD 2019 (accessed 2022)
357 (241 - 505) 2018 Modelled IHME, GBD 2019 (accessed 2022)
354 (237 - 506) 2019 Modelled IHME, GBD 2019 (accessed 2022)
354 (237 - 506) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (2 - 5) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3 (2 - 5) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 8) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2010 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2012 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2013 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2015 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2016 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2014 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2017 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2018 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 9) 2019 Modelled IHME, GBD 2019 (accessed 2022)
19 (14 - 26) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
98 2019 Survey/reported WHO/UNICEF
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
98 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
98 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
97 2020 Survey/reported WHO/UNICEF
98 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2019 Survey/reported WHO/UNICEF
97 2020 Survey/reported WHO/UNICEF
98 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
27 (16 - 72) 2016 Survey/reported Kecina EA, 2016.
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2005
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
NSP in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.3 (1.88 - 2.81) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.88 - 2.82) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.87 - 2.85) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.88 - 2.85) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.90 - 2.88) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.35 (1.92 - 2.89) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.38 (1.95 - 2.91) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.4 (1.96 - 2.94) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.95 - 2.95) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.42 (1.95 - 2.96) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.94 - 2.94) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.4 (1.94 - 2.92) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.38 (1.93 - 2.90) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.92 - 2.87) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.91 - 2.85) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.90 - 2.82) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.29 (1.87 - 2.78) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.26 (1.84 - 2.76) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.22 (1.81 - 2.73) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.19 (1.77 - 2.70) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.75 - 2.66) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.73 - 2.61) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.70 - 2.56) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.67 - 2.53) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.03 (1.65 - 2.50) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.02 (1.64 - 2.48) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.64 - 2.48) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.63 - 2.48) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.62 - 2.48) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.61 - 2.49) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.18 (1.78 - 2.67) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
3.39 (0.05 - 3.51) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.3 (0.90 - 2.90) 2014 Survey/reported Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
58.3 (43.30 - 73.30) 2015 Modelled Degenhardt L et al, 2017
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
199,481 (160,535 - 248,128) 1990 Modelled IHME, GBD 2019 (accessed 2022)
199,761 (162,102 - 247,654) 1991 Modelled IHME, GBD 2019 (accessed 2022)
200,316 (163,286 - 247,258) 1992 Modelled IHME, GBD 2019 (accessed 2022)
201,009 (163,771 - 246,885) 1993 Modelled IHME, GBD 2019 (accessed 2022)
201,722 (163,876 - 248,318) 1994 Modelled IHME, GBD 2019 (accessed 2022)
202,403 (164,748 - 249,071) 1995 Modelled IHME, GBD 2019 (accessed 2022)
203,766 (165,773 - 250,326) 1996 Modelled IHME, GBD 2019 (accessed 2022)
206,156 (168,536 - 253,426) 1997 Modelled IHME, GBD 2019 (accessed 2022)
209,017 (170,773 - 257,139) 1998 Modelled IHME, GBD 2019 (accessed 2022)
211,802 (172,515 - 261,472) 1999 Modelled IHME, GBD 2019 (accessed 2022)
214,100 (173,590 - 264,028) 2000 Modelled IHME, GBD 2019 (accessed 2022)
216,139 (175,730 - 265,291) 2001 Modelled IHME, GBD 2019 (accessed 2022)
218,091 (177,500 - 265,890) 2002 Modelled IHME, GBD 2019 (accessed 2022)
219,841 (179,636 - 266,917) 2003 Modelled IHME, GBD 2019 (accessed 2022)
221,283 (180,764 - 268,678) 2004 Modelled IHME, GBD 2019 (accessed 2022)
222,040 (181,248 - 270,270) 2005 Modelled IHME, GBD 2019 (accessed 2022)
222,499 (181,275 - 270,351) 2006 Modelled IHME, GBD 2019 (accessed 2022)
223,241 (181,322 - 271,381) 2007 Modelled IHME, GBD 2019 (accessed 2022)
223,986 (181,453 - 273,387) 2008 Modelled IHME, GBD 2019 (accessed 2022)
224,424 (180,526 - 273,606) 2009 Modelled IHME, GBD 2019 (accessed 2022)
224,311 (180,210 - 273,923) 2010 Modelled IHME, GBD 2019 (accessed 2022)
222,966 (179,928 - 271,898) 2011 Modelled IHME, GBD 2019 (accessed 2022)
220,619 (179,515 - 269,425) 2012 Modelled IHME, GBD 2019 (accessed 2022)
217,915 (178,195 - 266,255) 2013 Modelled IHME, GBD 2019 (accessed 2022)
215,291 (176,158 - 264,401) 2014 Modelled IHME, GBD 2019 (accessed 2022)
213,379 (173,733 - 262,935) 2015 Modelled IHME, GBD 2019 (accessed 2022)
210,681 (171,429 - 259,380) 2016 Modelled IHME, GBD 2019 (accessed 2022)
208,446 (169,959 - 258,898) 2017 Modelled IHME, GBD 2019 (accessed 2022)
207,971 (171,221 - 255,895) 2018 Modelled IHME, GBD 2019 (accessed 2022)
206,907 (168,822 - 253,619) 2019 Modelled IHME, GBD 2019 (accessed 2020)
207,744 (169,693 - 254,433) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
73,800 (1,100 - 76,500) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
5.23 (3.57 - 7.59) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.73 (1.32 - 2.28) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.38 - 2.37) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.43 - 2.46) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.65 - 2.82) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.59 - 2.73) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.35 (1.79 - 3.09) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.41 (1.85 - 3.18) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.52 (1.93 - 3.31) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.07 - 3.54) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.27 - 3.90) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.11 (2.38 - 4.07) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.55 (2.69 - 4.66) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.28 (3.26 - 5.62) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.51 (3.44 - 6) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.75 (3.61 - 6.34) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.3 (4.01 - 7.10) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.56 (4.22 - 7.44) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.21 (4.72 - 8.30) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.81 (4.41 - 7.78) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.65 (5.02 - 8.87) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7.02 (5.29 - 9.39) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7.29 (5.47 - 9.73) 2011 Modelled IHME, GBD 2019 (accessed 2022)
6.16 (4.71 - 8.13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.95 (4.50 - 7.92) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.41 (4.06 - 7.19) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.73 (4.37 - 7.56) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.27 (3.98 - 7.01) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.24 (3.78 - 7.16) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.21 (3.69 - 7.51) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.23 (3.57 - 7.59) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
486 2016 Modelled WHO
497 (339 - 721) 2019 Modelled IHME, GBD 2019 (accessed 2022)
497 (339 - 721) 2019 Modelled IHME, GBD 2019 (accessed 2020)
496 (351 - 715) 2018 Modelled IHME, GBD 2019 (accessed 2022)
500 (361 - 683) 2017 Modelled IHME, GBD 2019 (accessed 2022)
504 (381 - 670) 2016 Modelled IHME, GBD 2019 (accessed 2022)
518 (389 - 688) 2015 Modelled IHME, GBD 2019 (accessed 2022)
549 (419 - 725) 2014 Modelled IHME, GBD 2019 (accessed 2022)
571 (432 - 761) 2013 Modelled IHME, GBD 2019 (accessed 2022)
592 (453 - 782) 2012 Modelled IHME, GBD 2019 (accessed 2022)
703 (527 - 938) 2011 Modelled IHME, GBD 2019 (accessed 2022)
679 (512 - 909) 2010 Modelled IHME, GBD 2019 (accessed 2022)
646 (488 - 861) 2009 Modelled IHME, GBD 2019 (accessed 2022)
606 (460 - 809) 2008 Modelled IHME, GBD 2019 (accessed 2022)
569 (432 - 761) 2007 Modelled IHME, GBD 2019 (accessed 2022)
547 (415 - 731) 2006 Modelled IHME, GBD 2019 (accessed 2022)
524 (397 - 703) 2005 Modelled IHME, GBD 2019 (accessed 2022)
474 (360 - 632) 2004 Modelled IHME, GBD 2019 (accessed 2022)
453 (345 - 602) 2003 Modelled IHME, GBD 2019 (accessed 2022)
432 (329 - 568) 2002 Modelled IHME, GBD 2019 (accessed 2022)
361 (274 - 474) 2001 Modelled IHME, GBD 2019 (accessed 2022)
318 (244 - 416) 2000 Modelled IHME, GBD 2019 (accessed 2022)
306 (234 - 402) 1999 Modelled IHME, GBD 2019 (accessed 2022)
279 (214 - 367) 1998 Modelled IHME, GBD 2019 (accessed 2022)
262 (201 - 344) 1997 Modelled IHME, GBD 2019 (accessed 2022)
252 (193 - 331) 1996 Modelled IHME, GBD 2019 (accessed 2022)
246 (188 - 324) 1995 Modelled IHME, GBD 2019 (accessed 2022)
226 (174 - 296) 1994 Modelled IHME, GBD 2019 (accessed 2022)
218 (168 - 287) 1993 Modelled IHME, GBD 2019 (accessed 2022)
197 (150 - 259) 1992 Modelled IHME, GBD 2019 (accessed 2022)
188 (144 - 249) 1991 Modelled IHME, GBD 2019 (accessed 2022)
181 (138 - 239) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
4 (3 - 6) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 6) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 7) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2006 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2015 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2014 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2017 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2018 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
27 (19 - 35) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
27 (16 - 72) 2016 Survey/reported Kecina EA, 2016.
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2005
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
OST in at least one prison
No
NSP in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
354
2019
(237 - 506)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
497
2019
(339 - 721)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
98 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
27
2016
(16 - 72)
Kecina EA, 2016.
Eligible for HBV generic medicines
Eligible for HCV generic medicines